News

Humana (NYSE: HUM) stock has not been a favorite of investors this year, and the health insurer's first-quarter earnings report published Wednesday morning did nothing to change that. Following its

Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded

Shares of AT&T (NYSE: T) were moving higher today. Investors applauded its latest quarterly results as the telecom giant easily beat expectations on the top and bottom lines.

As a result, the

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

AT&T (NYSE: T)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

One of the best things about investing in stocks is that you don't always need share-price growth to make money. Thanks to dividends, investors can be rewarded regardless of a company's stock price

Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release

'Twas the morning after Earth Day, and all through Wall Street, lots of fuel cell stocks were stirring this morning. As of 10:20 a.m. ET, shares of Plug Power (NASDAQ: PLUG) had risen 8.2%, Bloom

Image source: The Motley Fool.

Novartis Ag (NYSE: NVS)Q1 2024 Earnings CallApr 23, 2024, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit

We have seen a stock pullback here in April, and three of these high-quality dividend paying stocks look quite intriguing. One of those stocks is healthcare company AbbVie (NYSE: ABBV) which I

Vertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years. The big biotech disappointed investors when a couple of candidates outside of its specialty area of

One of the hottest themes pushing the S&P 500 and Nasdaq Composite to new heights is artificial intelligence (AI). Applications from ChatGPT and competing platforms have taken the world by storm

As investing legends like Warren Buffett probably know better than anyone, there's something satisfying about buying shares of a company you intend to hold for the rest of your career as an

In this video, I will explain why semiconductor stocks like Nvidia, Intel, ARM Holdings (NASDAQ: ARM), and Advanced Micro Devices all crashed on Friday and whether or not this presents a buying

No risk, no reward. That's a fundamental part of investing. However, some stocks are less risky than others and still offer strong growth prospects.

Three Motley Fool contributors think they've

If you're looking for dividend-paying stocks among members of the S&P 500, finding a yield high enough to inspire a purchase can be extra challenging these days. The average dividend-paying stock in

Many tech stocks recently dipped after a hotter-than-expected inflation report for March dampened hopes for brisk interest rate cuts throughout the rest of the year. The escalating conflict in the

Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion in revenue last year. While there is still

If you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be worth today? The answer will strike you as terrific or terrible: $840.

That answer will be terrible